Back
 JBM  Vol.4 No.8 , August 2016
Assessment of Iron Profile among Transfused Dependent Chronic Renal Failure Sudanese Patients
Abstract: Background: Anemia is one of the complications of chronic kidney disease (CKD) which necessitates multiple blood transfusions. These multiple transfusions are usually accompanied by Iron over load. The current study aimed to assess the Iron profile in Sudanese patients with chronic renal failure received regular blood transfused. Materials and Methods: A descriptive analytical case control study was performed in Alturki Teaching Hospital, Khartoum, Sudan. A total of 90 Sudanese were enrolled in this study (30 CKD patients under hemodialysis and undergo multiple blood transfusion, 30 CKD patients under hemodialysis but not blood transfusion and 30 healthy controls, 51 (57%) were male and 39 (43%) were females, their age ranged between 28 to 75 years. Iron profile (serum iron, serum ferritin and total iron binding capacity (TIBC)) were measured using full automated Chemical analyzer Mindray BS 200 (China). Data were analyzed by using statistical package for social sciences (SPSS) verssion16. Results: The present study showed that serum iron and serum ferritin of those under hemodialysis and received regular blood transfusion patient were significantly higher compared to those under hemodialysis and did not received regular blood transfusion patients (P value 0.000 and 0.01) respectively. Conclusion: Patients with chronic renal failure and under hemodialysis and receive regular and multiple transfusions are prone to iron overload.
Cite this paper: Alla, M. , Adam, K. and Mohammed, N. (2016) Assessment of Iron Profile among Transfused Dependent Chronic Renal Failure Sudanese Patients. Journal of Biosciences and Medicines, 4, 52-56. doi: 10.4236/jbm.2016.48007.
References

[1]   Anemia in CKD.
https://www.niddk.nih.gov/health-information/health-topics/kidney-disease/anemia-in-kidney-disease-and-dialysis/Pages/facts.aspx

[2]   (1968) Council on Food, Nutrition Committee on Iron Deficiency: Iron Deficiency in the United States. JAMA, 203, 119-124.

[3]   Haskins, D., Stevens, A.R. and Finchs, S.A. (1952) Iron Metabolism: Iron Stores in Man and Measured by Phlebotomy. Journal of Clinical Investigation, 31, 543-547.
http://dx.doi.org/10.1172/JCI102639

[4]   Daice and Lewis (2011) Practical Hematology: Estimation of Total Iron Binding Capacity. 11th Edition, 187.

[5]   Stivelman, J., Schulman, G., Fosburg, M., Lazarus, J.M. and Hakim, R.M. (1989) Kinetics and Efficacy of Deferoxamine in Iron-Overloaded Hemodialysis Patients. Kidney International, 36, 1125-1132.
http://dx.doi.org/10.1038/ki.1989.311

[6]   McCarthy, J.T., Johnson, W.J., Nixon, D.E., Jenson, B.M. and Moyer, T.P. (1989) Transfusional Iron Overload in Patients Undergoing Dialysis: Treatment with Erythropoietin and Phlebotomy. Journal of Laboratory and Clinical Medicine, 114, 193-199.

[7]   Finch, S.C. and Finch, C.A. (1955) Idiopathic Hemochromatosis, an Iron Storage Disease. Medicine, 34, 381-430.
http://dx.doi.org/10.1097/00005792-195512000-00001

[8]   National Kidney Foundation (2002) k\DOQI Clinical Practice Guideline for Chronic Kidney Disease: Evaluation, Classification, and Stratification. American Journal of Kidney Diseases, 39, s1-s266.

[9]   Brugnara, C. and Eckardt, K.U. (2011) Hematologic Aspects of Kidney Disease. In: Taal, M.W., Ed., Brenner and Rector’s the Kidney, 9th Edition, Saunders, Philadelphia, 2081-2120.

[10]   Eschbach, J.W. and Adamason, J.W. (1994) Iron over Load in Renal Failure. New York Blood Center, 515.

[11]   Canavese, C., Bergamo, D., Ciccone, G., et al. (2004) Harmful Iron over Load in Dialysis Patients. Kidney International, 65, 1091-1098.

[12]   Kouegnigan Rerambiah, L., Essola Rerambiah, L., Mbourou Etomba, A., Mouguiama, R.M., Issanga, P.B., Biyoghe, A.S., Batchilili, B., Akone Assembe, S. and Djoba Siawaya, J.F. (2015) Blood Transfusion, Serum Ferritin, and Iron in Hemodialysis Patients in Afric. Journal of Blood Transfusion, 720389.

 
 
Top